Radiofrequency ablation as a treatment tool for liver metastases of colorectal origin

Cancer Imaging

Volumn 11, Issue 1, 2011, Pages 23-30

  Hompes, D ^a   Prevoo, W ^a   Ruers, T ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Colorectal liver metastases; Radiofrequency ablation; Resectable; Unresectable

Indexed keywords

CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; COLORECTAL LIVER METASTASES; CONTROLLED STUDY; HUMAN; LIVER METASTASIS; MORBIDITY; MORTALITY; OVERALL SURVIVAL; PRACTICE GUIDELINE; PROGRESSION FREE SURVIVAL; RADIOFREQUENCY ABLATION; RECURRENCE RISK; REVIEW; SURGICAL MORTALITY;

CATHETER ABLATION; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; HUMANS; LIVER; LIVER NEOPLASMS; TREATMENT OUTCOME;

EID: 79959620829     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2011.0004     Document Type: Review

References (41)

1. House M, Ito H, G€onen M. Survival after hepatic resection for metastatic colorectal cancer: trends in outcome for 1,600 patients during 2 decades at a single institution. J Am Coll Surg 2010; 210: 744-5. doi:10.1016/j.jamcollsurg.2009.12.040. PMid:20421043.
2. Nordlinger B, Sorbye H, Glimelius B. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomized controlled trial. Lancet 2008; 371: 1007-16. doi:10.1016/S0140-6736(08)60455-9. PMid:18358928.
3. Mulier S, Ruers T, Jamart J. Radiorequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update. Dig Surg 2008; 25: 445-60. doi:10.1159/000184736. PMid:19212117.
4. Wong SL, Mangu PB, Choti MA. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol 2010; 28: 493-508. doi:10.1200/JCO.2009.23.4450. PMid:19841322.
5. Crocetti L, de Baere T, Lencioni R. Quality improvement guidelines for RFA of liver tumours. Cardiovasc Intervent Radiol 2010; 33: 11-17. doi:10.1007/s00270-009-9736-y. PMid:19924474.
6. Thomas K, Bream P, Berlin J. Use of percutaneous drainage to treat hepatic abscess after radiofrequency ablation of metastatic pancreatic adenocarcinoma. Am Surg 2004; 70: 496-9. PMid:15212401.
7. Wolpin B, Mayer. Systemic treatment of colorectal cancer. Gastroenterology 2008; 134: 1296-310. doi:10.1053/j.gastro.2008.02.098. PMid:18471507.
8. Lencioni R, Crocetti L, Pina MC. Percutaneous image-guided radiofrequency ablation of liver tumors. Abdom Imaging 2009; 34: 547-56. doi:10.1007/s00261- 008-9479-2. PMid:19030918.
9. Mulier S, Ni Y, Jamart J. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 2005; 242: 158-71. doi:10.1097/01.sla.0000171032.99149.fe. PMid:16041205.
10. Sørensen S, Mortensen F, Nielsen D. Radiofrequency ablation of colorectal liver metastases: long-term survival. Acta Radiol 2007; 48: 253-8. (Pubitemid 46589076)
11. Abitabile P, Hartl U, Lange J. Radiofrequency ablation permits an effective treatment fro colorectal liver metastases. Eur J Surg Oncol 2007; 33: 67-71. PMid:17174059. (Pubitemid 46131881)
12. Gillams A, Lees W. Five-year survival following radiofrequency ablation of small, solitary, hepatic colorectal metastases. J Vasc Interv Radiol 2008; 19: 712-7. doi:10.1016/j.jvir.2008.01.016. PMid:18440460.
13. Gillams A, Lees W. Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol 2009; 19: 1206-13. doi:10.1007/s00330-008-1258-5. PMid:19137310.
14. Siperstein A, Berber E, Ballem N. Survival after radiofrequency ablation of colorectal liver metastases: 10 years experience. Ann Surg 2007; 246: 559-65. doi:10.1097/SLA.0b013e318155a7b6. PMid:17893492.
15. Gurusamy K, Ramamoorthy R, Imber C. Surgical resection versus non-surgical treatment for hepatic node positive patients with colorectal liver metastases. Cochrane Database System Rev 2010; CD006797; doi: 10.1002/14651858.CD006797.pub2.
16. Gleisner A, Choti M, Pawlik T. Colorectal liver metastases: recurrence and survival following hepatic resection radiofrequency ablation and combined resection-radiofrequency ablation. Arch Surg 2008; 143: 1204-12. PMid:19075173.
17. Oshowo A, Gillams A, Harisson E. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg 2003; 90: 1240-3. doi:10.1002/bjs.4264. PMid:14515293.
18. Ruers T, Joosten J, Wiering B. Comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases: a prospective study. Ann Surg Oncol 2007; 14: 1161-9. doi:10.1245/s10434-006-9312-5. PMid:17195903.
19. Abdalla E, Vauthey J, Ellis L. Recurrence and outcomes following hepatic resection, radiofrequency ablation and combined resection/ablation for colorectal liver metastases. Ann Surg 2004; 239: 818-27. doi:10.1097/01.sla. 0000128305.90650.71. PMid:15166961.
20. Machi J, Oishi AJ, Sumida K. Long-term outcome of radiofrequency ablation for unresectable liver metastases from colorectal cancer: evaluation of prognostic factors and effectiveness in firstand second-line management. Cancer J 2006; 12: 318-26. doi:10.1097/00130404-200607000-00011. PMid:16925977.
21. Elias D, Baton O, Sideris L. Hepatectomy plus intraoperative radiofrequency ablation and chemotherapy to treat technically unresectable multiple colorectal liver metastases. J Surg Oncol 2005; 90: 36-42. doi:10.1002/jso.20237. PMid:15786433.
22. Leblanc F, Fonck M, Evrard S. Comparison of hepatic recurrences after resection or intraoperative radiofrequency ablation indicated by size and topographical characteristics of the metastases. Eur J Surg Oncol 2008; 34: 185-90. PMid:17998155.
23. Aloia T, Vauthey J, Loyer E. Solitary colorectal liver metastases: resection determines outcome. Arch Surg 2006; 141: 460-6; discussion 466-7. PMid:16702517.
24. White R, Avital I, D'Angelica M. Rates and patterns of recurrence for percutaneous radiofrequency ablation and open wedge resection for solitary colorectal liver metastases. J Gastrointest Surg 2007; 11: 256-63. doi:10.1007/s11605-007-0100-8. PMid:17458595.
25. Hur H, Ko Y, Min B. Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases. Am J Surg 2009; 197: 728-36. doi:10.1016/j.amjsurg.2008.04.013. PMid:18789428.
26. Abdalla E. Commentary: Radiofrequency ablation for colorectal liver metastases: do not blame the biology when it is the technology. Am J Surg 2009; 197: 737-9. doi:10.1016/j.amjsurg.2008.06.029. PMid:18789420.
27. Mulier S, Ni Y, Ruers T. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? Ann Surg Oncol 2008; 15: 144-57. doi:10.1245/s10434-007-9478-5. PMid:17906898.
28. Elias D, de Baere T, Smayra T. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumor recurrence after hepatectomy. Br J Surg 2002; 89: 752-6. doi:10.1046/j.1365-2168.2002.02081.x. PMid:12027986.
29. Birth M, Hildebrand P, Dahmen G. Aktueller Stand der Radiofrequenzablation von lebertumoren: eine deutschlandweite Umfrage. Chirurg 2004; 75: 417-23. doi:10.1007/s00104-003-0801-9. PMid:15085282.
30. Cha C, Lee F, Gurney J. CT versus sonography for monitoring radiofrequency ablation in a porcine liver. Am J Roentgenol 2000; 175: 705-11.
31. Joosten J, Ruers T. Local radiofrequency ablation techniques for liver metastases of colorectal cancer. Crit Rev Oncol Hematol 2007; 62: 153-63. doi:10.1016/j.critrevonc.2006.12.001. PMid:17317204.
32. Meloni M, Goldberg N, Livraghi T. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT. Am J Roentgenol 2001; 177: 375-80. (Pubitemid 32660498)
33. Mahnken A, Buecker A, Spuentrup E. MR-guided radiofrequecy ablation of hepatic malignancies at 1.5T: initial results. J Magn Reson Imaging 2004; 19: 342-8. doi:10.1002/jmri.20004. PMid:14994303.
34. Lencioni R, Crocetti L, Cioni D. Percutaneous radiofrequency ablation of hepatic colorectal metastases: technique, indications, results and new promises. Invest Radiol 2004; 39: 689-97. doi:10.1097/00004424-200411000-00007. PMid:15486530.
35. de Baere T, Elias D, Dromain C. Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. Am J Roentgenol 2000; 175: 1619-25.
36. Helmberger T, Holzknecht N, Schöpf U. Radiofrequency ablation of liver metastases. Technique and initial results. Radiologe 2001; 41: 69-76. doi:10.1007/s001170050929. PMid:11220100.
37. Veltri A, Sacchetto P, Tosetti I. Radiofrequency ablation of colorectal liver metastases: small size favourably predicts technique effectiveness and survival. Cardiovasc Intervent Radiol 2008; 31: 948-56. doi:10.1007/s00270-008- 9362-0. PMid:18506519.
38. Solbiati L, Ierace T, Tonolini M. Radiofrequency thermal ablation of hepatic metastases. Eur J Ultrasound 2001; 13: 149-58. doi:10.1016/S0929- 8266(01)00127-6. PMid:11369526.
39. Jakobs T, Hoffmann R, Helmberger T. Radiofrequency ablation of colorectal liver metastases: mid-term results in 68 patients. Anticancer Res 2006; 26: 671-80. PMid:16739337. (Pubitemid 43206033)
40. Stang A, Fischbach R, Teichman W. A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases. Eur J Cancer 2009; 45: 1748-56. doi:10.1016/j.ejca.2009.03.012. PMid:19356924.
41. Curley A. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? Ann Surg Oncol 2007; 15: 11-13. doi:10.1245/s10434-007-9668-1. PMid:17955298.